American Bitcoin Corp. vs GoodRx
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- GoodRx is the larger company by market value: $1.2 B against $546 M for American Bitcoin Corp., 2.2 times as much (market caps of Oct 30, 2026 for American Bitcoin Corp. and Oct 14, 2026 for GoodRx).
- GoodRx had more revenue: $797 M against $185 M for American Bitcoin Corp., both in the year to December 2025.
- GoodRx made a net profit of $30 M, while American Bitcoin Corp. made a net loss of $153 M.
- GoodRx keeps more of each dollar of sales: a net margin of 3.8% against -82.7% for American Bitcoin Corp.
- American Bitcoin Corp.'s revenue grew faster in its latest fiscal year: +158.8% against +0.6% for GoodRx.
- Both are in the distress zone of the Altman Z-score.
Market value, the same start = 100
From Jan 2021: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | American Bitcoin Corp. ABTC · #12,158 in the world | GoodRx GDRX · #8,585 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Information Services | Healthcare Information Services |
| Founded | — | 2011 |
| Size | ||
| Market cap | $546 M | $1.2 B |
| Revenue | $185 M | $797 M |
| Net income | $-153 M | $30 M▲ best |
| Employees | — | 954 |
| Valuation | ||
| P/E ratio | — | 72.4× |
| Price to sales | 2.0× | 1.5× |
| Price to book | 0.8× | 1.9× |
| Free cash flow yield | -11.1% | 14.0%▲ best |
| Profitability | ||
| Gross margin | 50.3% | — |
| Operating margin | -123.1% | 11.0%▲ best |
| Net margin | -82.7% | 3.8%▲ best |
| Return on equity | -18.2% | 4.5%▲ best |
| Return on invested capital | — | 5.8% |
| Growth | ||
| Revenue growth | 158.8%▲ best | 0.6% |
| Revenue growth, 3 years a year | 160.6%▲ best | 1.3% |
| Earnings per share growth | — | 125.0% |
| Financial strength | ||
| Debt to equity | — | 0.8× |
| Net debt to EBITDA | — | 1.4× |
| Cash | ||
| Free cash flow margin | — | 20.6% |
| Shareholder returns | ||
| Shareholder yield | — | 18.4% |
| Altman Z-score zone | distress | distress |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, American Bitcoin Corp. or GoodRx?
GoodRx is the larger company by market value: $1.2 B against $546 M for American Bitcoin Corp., 2.2 times as much (market caps of Oct 30, 2026 for American Bitcoin Corp. and Oct 14, 2026 for GoodRx).
Which makes more money, American Bitcoin Corp. or GoodRx?
GoodRx had more revenue: $797 M against $185 M for American Bitcoin Corp., both in the year to December 2025. GoodRx made a net profit of $30 M, while American Bitcoin Corp. made a net loss of $153 M.
Which is more profitable, American Bitcoin Corp. or GoodRx?
GoodRx keeps more of each dollar of sales: a net margin of 3.8% against -82.7% for American Bitcoin Corp.
Which is growing faster, American Bitcoin Corp. or GoodRx?
American Bitcoin Corp.'s revenue grew faster in its latest fiscal year: +158.8% against +0.6% for GoodRx.
Which is financially stronger, American Bitcoin Corp. or GoodRx?
Both are in the distress zone of the Altman Z-score.